RS

Ramya Sridharan

Active Director Additional Director DIN 11219689
DIN 11219689 First appointment Jun 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value •••• Premium profile

About Ramya Sridharan

Data last updated:

Ramya Sridharan is an Additional Director at Dk Speciality Hospitals Private Limited (since 2025). The company operates in Healthcare. Dk Speciality Hospitals Private Limited reported revenue of ₹2.29 Cr (FY 2025).

DIN 11219689
Primary Designation Additional Director
Industry Healthcare
First Appointment 26 Jun 2025
Largest company Dk Speciality Hospitals Private Limited · ₹2.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director26 Jun 2025₹2.29 Cr (FY 2025)Active

Board colleagues of Ramya Sridharan

Directorship timeline

Open interactive timeline →
Dk Speciality Hospitals Private Limited
Premium access

Shareholding and investment profile for Ramya Sridharan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramya Sridharan

Ramya Sridharan currently holds 1 directorship: Dk Speciality Hospitals Private Limited (Additional Director, since 26 Jun 2025, revenue ₹2.29 Cr (FY 2025)).

Ramya Sridharan was first appointed on 26 Jun 2025 as Additional Director at Dk Speciality Hospitals Private Limited.

The current boards of Ramya Sridharan's companies include Dhamodaran Kaliyamoorthy (Dk Speciality Hospitals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available